COVID-19 Update: UH has visitor restrictions in place to protect patients and staff against coronavirus. Permitted visitors will be screened for flu-like symptoms. Click here for additional information on non-essential appointments, testing locations, COVID-19 information and how you can help during this crisis.

UH Seidman Cancer Center

Hematologic Malignancies Program

Download Hematologic Malignancies Program PDF

 

HOSPITAL
University Hospitals Seidman Cancer Center

KEY CONTACTS
Brenda Cooper, MD, Disease Team Leader, Medical Oncology 216-844-3213, Brenda.Cooper@UHhospitals.org
Marcos de Lima, MD, Director, Stem Cell Transplant 216-844-0139, Marcos.deLima@UHhospitals.org

For hospital transfers, please call 216-844-1111.

Conditions Treated

  • Leukemia
    Acute lymphoblastic leukemia
    Acute myeloid leukemia
    Chronic lymphocytic leukemia
    Chronic myelogenous leukemia
  • Lymphomas
    Non-Hodgkin lymphoma
    Hodgkin lymphoma
    Primary CNS lymphoma
  • Myeloma
  • Marrow failure syndromes

Therapies

  • Stem cell transplantation and other novel cellular therapies
  • Biological therapy
  • Radiation therapy
  • Chemotherapy

Distinguishing Features

  • Part of NCI-designated Case Comprehensive Cancer Cente
  • Accredited by the Foundation for the Accreditation of Cellular Therap
  • Partner with National Center for Stem Cell and Regenerative Medicine to study and develop new stem cell-based therapies
  • Stem Cell Transplant Clinical Trials Network member
  • University Hospitals Rainbow Babies & Children’s Hospital member of the Pediatric Blood and Stem Cell Transplant Consortium
  • Specialized Adolescent and Young Adult (AYA) cancer program
  • Extensive portfolio of clinical trials of new treatments
Back to Top